| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
89,554,000 |
| Market
Cap: |
2.19(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$20.02 - $46.03 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Intellia Therapeutics is a genome editing company focused on developing therapeutics using CRISPR/Cas9 technology. CRISPR/Cas9, an acronym for Clustered, Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR associated 9 (Cas9), is a technology for genome editing, the process of altering selected sequences of genomic deoxyribonucleic acid (DNA). To realize the transformative potential of CRISPR/Cas9-based technologies, Co. is building a range of genome editing company, by utilizing its modular platform, to advance in vivo and ex vivo therapies for diseases with high unmet need.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,902 |
53,430 |
61,187 |
62,275 |
| Total Sell Value |
$95,737 |
$1,583,155 |
$1,913,663 |
$1,961,404 |
| Total People Sold |
2 |
7 |
8 |
8 |
| Total Sell Transactions |
2 |
10 |
15 |
16 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rivera Jose E |
EVP, General Counsel |
• – – |
2021-01-05 |
4 |
S |
$55.86 |
$116,077 |
D/D |
(2,078) |
51,990 |
|
-10% |
|
| Schiermeier Andrew |
EVP, Chief Operating Officer |
• – – |
2021-01-05 |
4 |
S |
$55.86 |
$76,919 |
D/D |
(1,377) |
16,656 |
|
-10% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,375 |
481,727 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
54,068 |
|
- |
|
| Schiermeier Andrew |
EVP, Chief Operating Officer |
• – – |
2020-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,792 |
18,033 |
|
- |
|
| Schiermeier Andrew |
EVP, Chief Operating Officer |
• – – |
2020-12-30 |
4 |
OE |
$13.48 |
$20,220 |
D/D |
1,500 |
12,673 |
|
- |
|
| Karsen Perry A |
Director |
– • – |
2020-12-17 |
4 |
AS |
$52.52 |
$4,753,680 |
D/D |
(88,764) |
5,000 |
|
47% |
|
| Karsen Perry A |
Director |
– • – |
2020-12-17 |
4 |
OE |
$14.35 |
$1,637,842 |
D/D |
88,764 |
93,764 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-12-01 |
4 |
AS |
$37.73 |
$128,525 |
D/D |
(3,364) |
48,708 |
|
86% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-12-01 |
4 |
OE |
$13.88 |
$69,400 |
D/D |
5,000 |
52,072 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-27 |
4 |
AS |
$38.00 |
$1,350,000 |
D/D |
(35,000) |
467,352 |
|
79% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-27 |
4 |
OE |
$14.58 |
$566,100 |
D/D |
35,000 |
487,352 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-25 |
4 |
AS |
$36.00 |
$1,800,000 |
D/D |
(50,000) |
467,352 |
|
104% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-25 |
4 |
OE |
$6.83 |
$341,500 |
D/D |
50,000 |
517,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-18 |
4 |
AS |
$35.00 |
$21,840 |
D/D |
(624) |
47,072 |
|
134% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-18 |
4 |
OE |
$18.30 |
$15,518 |
D/D |
848 |
47,696 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-16 |
4 |
AS |
$33.75 |
$206,728 |
D/D |
(6,029) |
46,848 |
|
90% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-16 |
4 |
OE |
$6.83 |
$78,585 |
D/D |
10,562 |
47,262 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-16 |
4 |
AS |
$34.00 |
$680,000 |
D/D |
(20,000) |
467,352 |
|
90% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-16 |
4 |
OE |
$14.58 |
$291,600 |
D/D |
20,000 |
487,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-04 |
4 |
AS |
$28.00 |
$94,192 |
D/D |
(3,364) |
42,315 |
|
147% |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-11-04 |
4 |
OE |
$13.88 |
$69,400 |
D/D |
5,000 |
45,679 |
|
- |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-04 |
4 |
AS |
$26.00 |
$1,300,000 |
D/D |
(50,000) |
467,352 |
|
147% |
|
| Leonard John M. |
President and CEO |
• • – |
2020-11-04 |
4 |
OE |
$6.83 |
$341,500 |
D/D |
50,000 |
517,352 |
|
- |
|
| Rivera Jose E |
EVP, General Counsel |
• – – |
2020-10-15 |
4 |
AS |
$24.19 |
$135,883 |
D/D |
(5,615) |
40,679 |
|
137% |
|
245 Records found
|
|
Page 7 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.40 (1.61%) 
